ArticleScientific reports2021

Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M.

Yen-Hsiang Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.